The Evidence Gap: Costly Cancer Drug Offers Hope, but Also a Dilemma
July 6th, 2008 by
Avastin, which can cost as much as $100,000 a year, has become one of the most popular cancer drugs, but studies show it prolongs life by only a few months.
Posted in Lungs, Colon, Avastin (Drug), Genentech Inc|DNA|NYSE, Tumors, Breast, Cancer, Medicine and Health, Drugs (Pharmaceuticals), Health Insurance and Managed Care